ZyVersa Therapeutics (ZVSA) Earnings Date, Estimates & Call Transcripts $0.15 +0.00 (+0.40%) As of 03:51 PM Eastern Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZyVersa Therapeutics Earnings Summary ZyVersa Therapeutics posted Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.73, which missed analysts' consensus estimates of -$0.40 by $0.33. With a trailing EPS of $0.00, ZyVersa Therapeutics' earnings are expected to decrease next year, from ($22.70) to ($46.10) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)Powered by Latest Q1 Earnings DateMay. 12EstimatedConsensus EPS (May. 12) -$0.40 Actual EPS (May. 12) -$0.73 Missed By -$0.33 Get ZyVersa Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZyVersa Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataZVSA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. ZyVersa Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($22.70) EPSNext Year EPS Consensus Estimate ($46.10) EPS ZyVersa Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025-$0.40-$0.73 -$0.33-$0.73--8/9/2024--$5.20-$3.31+$1.89-$3.31--5/15/2024Q1 2024-$3.70-$4.53 -$0.83-$4.53--11/14/2023Q3 2023-$56.00-$31.50+$24.50-$0.09--8/21/2023Q2 2023--$1,459.50--$3.50-- ZyVersa Therapeutics Earnings - Frequently Asked Questions When did ZyVersa Therapeutics announce their last quarterly earnings? ZyVersa Therapeutics (NASDAQ:ZVSA) last announced its quarterly earning data on Monday, May 12, 2025. Learn more on ZVSA's earnings history. Did ZyVersa Therapeutics beat their earnings estimates last quarter? In the previous quarter, ZyVersa Therapeutics (NASDAQ:ZVSA) missed the analysts' consensus estimate of ($0.40) by $0.33 with a reported earnings per share (EPS) of ($0.73). Learn more on analysts' earnings estimate vs. ZVSA's actual earnings. How much profit does ZyVersa Therapeutics generate each year? ZyVersa Therapeutics (NASDAQ:ZVSA) has a recorded net income of -$9.41 million. ZVSA has generated $0.00 earnings per share over the last four quarters. What is ZyVersa Therapeutics' EPS forecast for next year? ZyVersa Therapeutics' earnings are expected to decrease from ($22.70) per share to ($46.10) per share in the next year. More Earnings Resources from MarketBeat Related Companies CNS Pharmaceuticals Earnings Date GRI Bio Earnings Date Qualigen Therapeutics Earnings Date UNITY Biotechnology Earnings Date CERo Therapeutics Earnings Date Lipella Pharmaceuticals Earnings Date Enveric Biosciences Earnings Date Psyence Biomedical Earnings Date PainReform Earnings Date Heatwurx Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Brinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings Beat This page (NASDAQ:ZVSA) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access